CLPT (clearpointneuro.com) Market Value to Book Value Ratio

clearpointneuro.com (CLPT) - corporate logo

The market trend for ClearPoint Neuro, Inc. (CLPT) shares on the GURU.Markets platform reflects the dynamics of a company that develops neurosurgical navigators. Revenue is based on the sale of disposable catheters and licenses, which ensures 25.78. High physician loyalty to proprietary software and equipment guarantees zero customer churn. However, the slow adoption of robotics in medicine and the rise of non-invasive treatment methods create certain risks.

Market Capitalization to Net Assets: clearpointneuro.com (CLPT) for 07/04/2022 - 10/27/2026
Finished products of ClearPoint Neuro, Inc.

This ratio measures the market premium over net book value, determining the extent to which quotes are inflated relative to the company's tangible assets. By analyzing the historical P/BV ratio, an investor can assess the risk of a valuation correction for ClearPoint Neuro (CLPT), whose market capitalization relies on the potential for recurring revenue from the sale of disposable catheters and neurosurgery licenses.

Direct competitors

BSX - Market Cap to Net Assets Ratio|EW (edwards.com) - Market Cap to Book Value Multiple|RMD: Market Value to Book Value Ratio|Market Capitalization to Book Value PODD|ZBH - Market Value to Book Value Ratio|Market Capitalization to Net Assets CooperSurgical (COO)|ALGN: Market Capitalization to Book Value Ratio|Market-to-Book Ratio globusmedical.com GMED|TMDX: Market Capitalization to Book Value Ratio|ATEC - Market Cap to Net Assets Ratio|Artivion Inc - Market Capitalization to Book Value Ratio|Enovis Inc. (ENOV) - Market Capitalization to Book Value|IART (Integra LifeSciences) - Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Ratio ESTA|Market Value to Book Value Ratio Beta Bionics (BBNX)|Market Value to Book Value Ratio IRADIMED Corp (IRMD)|Market Capitalization to Book Value Ratio EMBC|TNDM - Market Capitalization to Book Value|Market Cap to Net Assets Ratio AxoGen, Inc.|SIBN - Market Capitalization to Net Assets|Market Capitalization to Book Value Ratio OFIX|Bioventus Inc (BVS) - Market-to-Book Ratio|Market Capitalization to Book Value Ratio OrthoPediatrics Corp (KIDS)|Capitalization to Book Value Ratio Treace Corp (TMCI)|Strata Critical Medical Inc (SRTA) - Market Cap to Net Assets Ratio|Market Value to Book Value CARL (carlsmed.com)|RxSight - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Stereotaxis Inc STXS|STIM (NeuroStar) - Market Capitalization to Book Value Ratio|SGHT - Market-to-Book Ratio|Market Capitalization to Book Value Ratio Orchestra BioMed|Anika Therapeutics, Inc. (ANIK) - Capitalization to Book Value Ratio|NSPR: Market Capitalization to Book Value Ratio|Market Capitalization to Book Value Jin Medical International Ltd|Market Capitalization to Book Value Ratio VANI (Vivani Medical, Inc.)|Market Cap to Net Assets Ratio xtantmedical.com (XTNT)|Market Capitalization to Book Value Ratio NMTC (NeuroOne Medical Technologies)|Modular Medical Inc - Market Capitalization to Book Value Ratio|MYO - Market Value to Book Value Ratio|Envoy Medical Inc. (COCH) - Market Value to Book Value Ratio|Market Cap to Net Assets Ratio Vivos Therapeutics, Inc VVOS|enVVeno Corp (NVNO) - Market Value to Book Value|Market Capitalization to Book Value Ratio SINT (Sintx Technologies Inc)|Market-to-Book Ratio TNON|LFWD: Market Value to Book Value Ratio|Market Value to Equity Ratio autonomix.com AMIX|Market Cap to Net Assets Ratio IVF (INVO Bioscience, Inc.)|Market Capitalization to Book Value Ratio Bone Biologics Inc BBLG|Market Capitalization to Book Value Ratio AXNX (Axonics, Inc.)|BIOL: Market Capitalization to Book Value|Market Value to Book Value Ratio dynatronics.com (DYNT)|FNA (Paragon 28) - Market Capitalization to Net Assets|Market Value to Book Value Ratio INVO